Research
The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid
Head & Neck Oncology 2012, 4:15 doi:10.1186/1758-3284-4-15
No comments have yet been made on this article.
Research
